James E. Levine, Chief Financial Officer at Cardiff Oncology, Inc. (CRDF), bought 7,716 shares at $3.83 ($37K) on 2024-12-16, disclosed to the SEC on 2024-12-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.83 | 2,564 | $10K | 26.7% |
| 2 | $5.42 | 2,752 | $15K | 40.6% |
| 3 | $5.00 | 2,400 | $12K | 32.7% |
| Total | $4.76 avg | 7,716 | $37K | 100% |
| Filing → |
| CDTX | BUY | 2020-11-12 | $201K | — | Filing → |
| CDTX | BUY | 2020-03-23 | $57K | — | Filing → |
| VRNM | BUY | 2012-05-16 | $18K | — | Filing → |